Kiniksa Pharmaceuticals International Plc (KNSA)
77.09
-0.82
(-1.05%)
USD |
NASDAQ |
Sep 08, 16:00
80.00
+2.91
(+3.77%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Debt to Equity Ratio : 0.0136 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0136 |
| March 31, 2026 | 0.0149 |
| December 31, 2025 | 0.0167 |
| September 30, 2025 | 0.0182 |
| June 30, 2025 | 0.0197 |
| March 31, 2025 | 0.0217 |
| December 31, 2024 | 0.0225 |
| September 30, 2024 | 0.0242 |
| June 30, 2024 | 0.0262 |
| March 31, 2024 | 0.0281 |
| December 31, 2023 | 0.0279 |
| September 30, 2023 | 0.032 |
| June 30, 2023 | 0.0328 |
| March 31, 2023 | 0.0144 |
| December 31, 2022 | 0.0149 |
| September 30, 2022 | 0.0175 |
| June 30, 2022 | 0.0301 |
| March 31, 2022 | 0.0325 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.0327 |
| September 30, 2021 | 0.0315 |
| June 30, 2021 | 0.026 |
| March 31, 2021 | 0.0243 |
| December 31, 2020 | 0.0224 |
| September 30, 2020 | 0.0043 |
| June 30, 2020 | 0.0073 |
| March 31, 2020 | 0.0109 |
| December 31, 2019 | 0.0118 |
| September 30, 2019 | 0.0119 |
| June 30, 2019 | 0.012 |
| March 31, 2019 | 0.0118 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 896.11M |
| Total Liabilities (Quarterly) | 241.96M |
| Shareholders Equity (Quarterly) | 654.15M |
| Current Ratio | 3.904 |
| Net Debt Paydown Yield | 0.00% |